Literature DB >> 3082561

Parenteral nutrition and hepatobiliary dysfunction.

M K Farrell, W F Balistreri.   

Abstract

Parenteral nutrition associated cholestasis is a condition that challenges even the most astute clinician. The risk:benefit ratio of parenteral nutrition must be individualized for each neonate. The dilemma is based on weighing the risk of progressive cholestasis and its complications against the risk of starvation, malnutrition, and their consequences. Avoiding excessive nutrient infusion and providing even minimal enteral calories may prevent or mitigate cholestasis. Routine monitoring of hepatic function in all neonates receiving parenteral nutrition allows early detection and intervention. Affected infants must be evaluated for treatable causes of neonatal cholestasis. Parenteral nutrition related cholestasis remains a diagnosis of exclusion. Further research is needed to unravel the cause and to define the long-term consequences of parenteral nutrition associated cholestasis.

Entities:  

Mesh:

Year:  1986        PMID: 3082561

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN: 0095-5108            Impact factor:   3.430


  3 in total

1.  Alteration of canalicular transporters in a mouse model of total parenteral nutrition.

Authors:  Yuko Tazuke; Daniel H Teitelbaum
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-02       Impact factor: 2.839

2.  Continuous extracorporeal stool-transport system: a new and economical procedure for transitory short-bowel syndrome in prematures and newborns.

Authors:  K Schäfer; Z Zachariou; W Löffler; R Daum
Journal:  Pediatr Surg Int       Date:  1997       Impact factor: 1.827

3.  Editing Myosin VB Gene to Create Porcine Model of Microvillus Inclusion Disease, With Microvillus-Lined Inclusions and Alterations in Sodium Transporters.

Authors:  Amy C Engevik; Alexander W Coutts; Izumi Kaji; Paula Rodriguez; Felipe Ongaratto; Milena Saqui-Salces; Ramya Lekha Medida; Anne R Meyer; Elena Kolobova; Melinda A Engevik; Janice A Williams; Mitchell D Shub; Daniel F Carlson; Tamene Melkamu; James R Goldenring
Journal:  Gastroenterology       Date:  2020-02-26       Impact factor: 22.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.